Industry sponsorship and research outcome: systematic review with meta-analysis
- 21 August 2018
- journal article
- review article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (10) , 1603-1612
Abstract
Clinical research is widely sponsored by drug and device companies. We investigated whether industry sponsored drug and device studies have more favorable outcomes and differ in risk of bias, compared with studies having other sources of sponsorship. This review is an update of a previous Cochrane review.Keywords
This publication has 56 references indexed in Scilit:
- Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trialsBMC Medicine, 2013
- Why we need easy access to all data from all clinical trials and how to accomplish itTrials, 2011
- Reporting bias in medical research - a narrative reviewTrials, 2010
- Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and PresentationPLOS Medicine, 2008
- Evolution of the Randomized Controlled Trial in Oncology Over Three DecadesJournal of Clinical Oncology, 2008
- Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry‐funded studies?British Journal of Clinical Pharmacology, 2008
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting BiasPLOS ONE, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than OthersPLOS Medicine, 2007
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004